Compare SBAC & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SBAC | DXCM |
|---|---|---|
| Founded | 1989 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.1B | 26.5B |
| IPO Year | 1999 | 2005 |
| Metric | SBAC | DXCM |
|---|---|---|
| Price | $201.00 | $61.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 21 |
| Target Price | ★ $233.12 | $85.33 |
| AVG Volume (30 Days) | 817.8K | ★ 4.5M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | 41.21 | ★ 47.18 |
| EPS | ★ 1.74 | 0.51 |
| Revenue | ★ $2,815,139,000.00 | N/A |
| Revenue This Year | $2.80 | $14.46 |
| Revenue Next Year | $2.76 | $12.31 |
| P/E Ratio | $115.29 | ★ $113.50 |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $162.41 | $54.11 |
| 52 Week High | $243.16 | $89.07 |
| Indicator | SBAC | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 37.91 | 50.42 |
| Support Level | $186.85 | $56.72 |
| Resistance Level | $204.58 | $65.87 |
| Average True Range (ATR) | 5.65 | 2.33 |
| MACD | -3.01 | 0.16 |
| Stochastic Oscillator | 16.16 | 73.65 |
SBA Communications owns a portfolio of about 46,000 wireless towers throughout North America, South America, and Africa. It leases space on its towers to wireless service providers, who install equipment to support their wireless networks. The company has a very concentrated customer base, with most revenue in each market generated by the top few mobile carriers. It owns more than 17,000 towers in the US, which account for about 70% of leasing revenue. Internationally, SBA's largest markets are Brazil and Guatemala, where it owns roughly 12,000 and 5,000 towers, respectively. SBA operates as a real estate investment trust.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.